Inspra (eplerenone)

Detailed View: Safety Labeling Changes Approved By FDA Center for Drug Evaluation and Research (CDER) May 2016 WARNINGS AND PRECAUTIONS Hyperkalemia The risk of hyperkalemia is higher in patients with impaired renal function,...
Source: Drugs.com - Labeling Changes - Category: Drugs & Pharmacology Source Type: alerts